Valo Therapeutics
Immunooncology platform developing tumor antigen-coated oncolytic viruses as therapeutic vaccines.
3
Funding Rounds
$26.7m
Money raised
Funding
Funding series
Funding Series Analysis
The company Valo Therapeutics has raised a total of $26.7m in funding over 3 rounds.
Key Insights:
- Valo Therapeutics , November 2021: $12.5m
- Valo Therapeutics November 2021 Funding Round: $13m
- Valo Therapeutics , February 2020: $1.2m
Valo Therapeutics , November 2021
$12.5m
Valo Therapeutics November 2021 Funding Round
$13m
Valo Therapeutics , February 2020
$1.2m
Industries
Valo Therapeutics is active in the following industries: